Financials

News Ideas Discussions Technicals Forecast Seasonals

CUV fundamentals

An in-depth look to Clinuvel Pharmaceuticals Limited operating, investing, and financing activities

CUV free cash flow for H2 25 is 27.7 M AUD. For 2025, CUV free cash flow was 40.8 M AUD and operating cash flow was 41.1 M AUD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: AUD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—